AVT32-DRL_PB
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVT32-DRL_PB, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma [Phase 1]